attachment
attachment
attachment
attachment
attachment
attachment

Give me notes of this textbook copy Use charts for pathophysiology Explain in easy language

analyse_media
analyse_media
analyse_media
Here are your complete, easy-to-read notes on GOUT with a pathophysiology flowchart:

🦡 GOUT - Complete Notes


πŸ“Œ What is Gout?

Gout is a type of sudden, painful joint inflammation caused by the build-up of monosodium urate (MSU) crystals in and around joints.
  • Prevalence: 1% to 4% of the population
  • More common in older men
  • Caused by too much uric acid in the blood (hyperuricemia)

⚠️ Causes / Risk Factors

CategoryExamples
GeneticFamily history, rare single gene defects
Medical conditionsKidney disease, diabetes
DietPurine-rich foods (seafood, offal), alcohol (especially beer)
MedicationsDiuretics, immunosuppressants, thiazides
Bottom line: No matter the cause, high uric acid = high risk of gout.

πŸ”¬ Pathophysiology (How it Happens)

High Purine Diet / Reduced Kidney Excretion
              ↓
        HYPERURICEMIA
    (too much uric acid in blood)
              ↓
    Uric acid exceeds saturation point
              ↓
    MSU CRYSTALS form & deposit in joints
              ↓
    Neutrophils & Macrophages arrive
    (immune cells rush to the joint)
              ↓
    NLRP3 Inflammasome gets activated
    (a sensor inside immune cells detects crystals)
              ↓
    Release of IL-1Ξ², TNF-Ξ±
    (pro-inflammatory chemicals)
              ↓
    πŸ”₯ INFLAMMATION β†’ Severe pain, redness, swelling
Key players:
  • IL-1Ξ² (Interleukin-1 beta) - main chemical causing inflammation
  • TNF-Ξ± - amplifies the inflammatory response
  • NLRP3 inflammasome - the "alarm system" inside immune cells

πŸ“Š 4 Stages of Gout (Clinical Features)

STAGE 1              STAGE 2              STAGE 3              STAGE 4
Asymptomatic    β†’  Acute Gout Attack  β†’  Intercritical     β†’  Chronic Tophaceous
Hyperuricemia                             Gout                  Gout

High uric acid     Sudden severe pain     Symptom-free          Permanent joint
but NO symptoms    in 1 joint (big toe)   period between        damage + tophi
                   Peaks in 12-24 hrs     attacks               (crystal lumps under
                   Resolves in 3-14 days  Crystals keep         skin)
                   on its own             depositing
Triggers for acute attacks:
  • Alcohol (beer especially)
  • Trauma to a joint
  • Dietary changes
  • Certain medications
Physical signs:
  • Red, hot, swollen, tender joint
  • Subcutaneous tophi (lumps under skin)
Recurrence statistics:
  • 60% get a second attack within 1 year
  • 80% within 3 years

πŸ§ͺ Diagnosis

Clinical Signs

  • Sudden severe joint pain, redness, warmth
  • Usually the big toe joint (first metatarsophalangeal joint)

Lab Tests

TestWhat it checks
Serum uric acidElevated in gout
Synovial fluid analysisMSU crystals under microscope (gold standard)
CBCRules out infection
ESR / CRPElevated during acute attack (inflammation markers)

Imaging

ImagingPurpose
X-rayJoint damage
UltrasoundCrystal deposits
DECT scanBest for detecting urate crystals
MRIInflammation, soft tissue

πŸ’Š Management

Acute Attack

DrugNotes
NSAIDsFirst line; use cautiously in elderly
Colchicine0.5 mg twice or three times daily
CorticosteroidsLocal injection or oral

Chronic / Recurrent Gout - Urate Lowering Therapy (ULT)

Target uric acid levels:
  • BSR guidelines: below 360 Β΅mol/L (6 mg/dL)
  • EULAR guidelines: below 300 Β΅mol/L (5 mg/dL)

Drug Choices:

FIRST LINE
    β”‚
    β–Ό
Allopurinol
- Start: 100 mg/day (lower if elderly or kidney problem)
- Max dose: 900 mg/day
- Add colchicine/NSAID prophylaxis for first few months
- Annual uric acid monitoring needed
    β”‚
    β–Ό (if allopurinol fails or contraindicated)
Febuxostat
- 80 mg/day
- More potent than allopurinol
- Prophylactic colchicine/NSAID for first 6 months
    β”‚
    β–Ό (if patient over-produces uric acid β†’ use uricosurics)
Uricosurics (Probenecid, Sulfinpyrazone)
- Increase uric acid excretion in urine
- Need high urine flow
- NOT for kidney disease or kidney stones
- Benzbromarone: can use in mild-moderate kidney impairment
  but has liver toxicity risk
    β”‚
    β–Ό (last resort - refractory tophaceous gout)
Pegloticase
- IV infusion every 2 weeks, up to 6 months
- Risk: infusion reactions and antibody development

Lifestyle Changes (Very Important!)

  • βœ… Lose weight
  • βœ… Drink plenty of water
  • βœ… Avoid alcohol (especially beer)
  • βœ… Avoid high-purine foods: seafood, offal (liver, kidney meat)
  • βœ… Stop thiazide diuretics if possible - switch to ACE inhibitors

πŸ—‚οΈ Quick Summary Table

FeatureDetails
CauseMSU crystal deposition due to high uric acid
Main joint affectedBig toe (1st MTP joint)
Key diagnostic testSynovial fluid - needle-shaped crystals
Acute treatmentNSAIDs, Colchicine, Steroids
Long-term treatmentAllopurinol (first choice)
LifestyleAvoid purines, alcohol; stay hydrated

Simple way to remember: More uric acid β†’ crystals in joints β†’ immune system overreacts β†’ painful swelling. Treat the attack, then lower uric acid long-term.

Can u make document and send

Reading File
Reading File
Running Command

ls /home/daytona/workspace/ 2>/dev/null && ls /home/daytona/skills/docx/scripts/…

Running Command

mkdir -p /home/daytona/workspace/gout-notes && ls /home/daytona/workspace/gout-n…

Writing File

~/gout-notes/create_gout_doc.js

const {
  Document, Packer, Paragraph, TextRun, Table, TableRow, TableCell,
  HeadingLevel, AlignmentType, BorderStyle, WidthType, ShadingType,
  LevelFormat, VerticalAlign, PageNumber, Header, Footer, TableBorders
} = require('docx');
const fs = require('fs');

// Color palette
const RED = "C0392B";
const ORANGE = "E67E22";
const BLUE = "1A5276";
const LIGHT_BLUE = "D6EAF8";
const LIGHT_ORANGE = "FDEBD0";
const LIGHT_RED = "FADBD8";
const LIGHT_GREEN = "D5F5E3";
const LIGHT_GRAY = "F2F3F4";
const WHITE = "FFFFFF";
const DARK_GRAY = "2C3E50";

function h(text, level, color) {
  return new Paragraph({
    heading: level,
    children: [new TextRun({ text, bold: true, color: color || BLUE, font: "Arial" })],
    spacing: { before: 240, after: 120 }
  });
}

function para(text, opts = {}) {
  return new Paragraph({
    children: [new TextRun({ text, font: "Arial", size: opts.size || 22, bold: opts.bold || false, color: opts.color || "000000", italics: opts.italics || false })],
    spacing: { before: opts.spaceBefore || 60, after: opts.spaceAfter || 60 },
    alignment: opts.align || AlignmentType.LEFT,
  });
}

function bullet(text, opts = {}) {
  return new Paragraph({
    numbering: { reference: "bullets", level: 0 },
    children: [
      new TextRun({ text: opts.label ? opts.label : "", bold: true, font: "Arial", size: 22, color: opts.labelColor || BLUE }),
      new TextRun({ text: opts.label ? " " + text : text, font: "Arial", size: 22, color: opts.color || "000000" })
    ],
    spacing: { before: 40, after: 40 }
  });
}

function spacer() {
  return new Paragraph({ children: [new TextRun("")], spacing: { before: 80, after: 80 } });
}

function sectionBox(title, color) {
  return new Paragraph({
    children: [new TextRun({ text: "  " + title + "  ", bold: true, color: WHITE, size: 28, font: "Arial" })],
    shading: { type: ShadingType.CLEAR, fill: color },
    spacing: { before: 200, after: 100 },
    indent: { left: 0 }
  });
}

function makeTable(headers, rows, headerBg) {
  const headerRow = new TableRow({
    children: headers.map(h => new TableCell({
      children: [new Paragraph({ children: [new TextRun({ text: h, bold: true, color: WHITE, font: "Arial", size: 20 })], alignment: AlignmentType.CENTER })],
      shading: { type: ShadingType.CLEAR, fill: headerBg || BLUE },
      verticalAlign: VerticalAlign.CENTER,
      margins: { top: 80, bottom: 80, left: 120, right: 120 }
    }))
  });

  const dataRows = rows.map((row, i) => new TableRow({
    children: row.map(cell => new TableCell({
      children: [new Paragraph({ children: [new TextRun({ text: cell, font: "Arial", size: 20 })], alignment: AlignmentType.LEFT })],
      shading: { type: ShadingType.CLEAR, fill: i % 2 === 0 ? WHITE : LIGHT_GRAY },
      margins: { top: 60, bottom: 60, left: 120, right: 120 }
    }))
  }));

  return new Table({
    width: { size: 100, type: WidthType.PERCENTAGE },
    rows: [headerRow, ...dataRows],
    margins: { top: 80, bottom: 80 }
  });
}

function flowBox(text, bg, textColor) {
  return new Paragraph({
    children: [new TextRun({ text, bold: true, color: textColor || WHITE, font: "Arial", size: 20 })],
    shading: { type: ShadingType.CLEAR, fill: bg },
    alignment: AlignmentType.CENTER,
    spacing: { before: 40, after: 0 },
    border: {
      top: { style: BorderStyle.SINGLE, size: 6, color: DARK_GRAY },
      bottom: { style: BorderStyle.SINGLE, size: 6, color: DARK_GRAY },
      left: { style: BorderStyle.SINGLE, size: 6, color: DARK_GRAY },
      right: { style: BorderStyle.SINGLE, size: 6, color: DARK_GRAY }
    },
    indent: { left: 720, right: 720 }
  });
}

function arrow() {
  return new Paragraph({
    children: [new TextRun({ text: "↓", bold: true, font: "Arial", size: 28, color: RED })],
    alignment: AlignmentType.CENTER,
    spacing: { before: 0, after: 0 }
  });
}

// Build document
const doc = new Document({
  numbering: {
    config: [
      {
        reference: "bullets",
        levels: [{ level: 0, format: LevelFormat.BULLET, text: "β€’", alignment: AlignmentType.LEFT, style: { paragraph: { indent: { left: 480, hanging: 240 } } } }]
      }
    ]
  },
  styles: {
    default: { document: { run: { font: "Arial", size: 22 } } },
    paragraphStyles: [
      { id: "Heading1", name: "Heading 1", basedOn: "Normal", next: "Normal", quickFormat: true,
        run: { size: 36, bold: true, color: WHITE, font: "Arial" },
        paragraph: { spacing: { before: 240, after: 120 }, outlineLevel: 0 } },
      { id: "Heading2", name: "Heading 2", basedOn: "Normal", next: "Normal", quickFormat: true,
        run: { size: 28, bold: true, color: BLUE, font: "Arial" },
        paragraph: { spacing: { before: 200, after: 100 }, outlineLevel: 1 } },
      { id: "Heading3", name: "Heading 3", basedOn: "Normal", next: "Normal", quickFormat: true,
        run: { size: 24, bold: true, color: ORANGE, font: "Arial" },
        paragraph: { spacing: { before: 140, after: 80 }, outlineLevel: 2 } },
    ]
  },
  sections: [{
    properties: {},
    children: [

      // ============ TITLE PAGE ============
      new Paragraph({
        children: [new TextRun({ text: "GOUT", bold: true, color: WHITE, font: "Arial", size: 72 })],
        shading: { type: ShadingType.CLEAR, fill: BLUE },
        alignment: AlignmentType.CENTER,
        spacing: { before: 400, after: 200 }
      }),
      new Paragraph({
        children: [new TextRun({ text: "Complete Medical Notes", bold: true, color: WHITE, font: "Arial", size: 30 })],
        shading: { type: ShadingType.CLEAR, fill: BLUE },
        alignment: AlignmentType.CENTER,
        spacing: { before: 0, after: 200 }
      }),
      new Paragraph({
        children: [new TextRun({ text: "Pathophysiology | Clinical Features | Diagnosis | Management", italics: true, color: DARK_GRAY, font: "Arial", size: 22 })],
        alignment: AlignmentType.CENTER,
        spacing: { before: 100, after: 400 }
      }),

      spacer(),

      // ============ SECTION 1: INTRODUCTION ============
      sectionBox("1. INTRODUCTION", BLUE),

      para("Gout is a type of sudden, painful joint inflammation caused by the build-up of monosodium urate (MSU) crystals in and around joints.", { spaceBefore: 100 }),

      spacer(),

      makeTable(
        ["Feature", "Detail"],
        [
          ["What is it?", "Acute inflammatory arthritis due to MSU crystal deposition"],
          ["Prevalence", "1% to 4% of the population"],
          ["Who gets it?", "More common in older men (advanced age + male gender = primary risk factors)"],
          ["Root cause", "Elevated uric acid in blood (Hyperuricemia)"]
        ],
        BLUE
      ),

      spacer(),

      h("Causes & Risk Factors", HeadingLevel.HEADING_2),

      makeTable(
        ["Category", "Examples"],
        [
          ["Genetic", "Family history, rare single gene defects"],
          ["Medical conditions", "Kidney disease, Diabetes"],
          ["Diet", "Purine-rich foods (seafood, offal), Alcohol (especially beer)"],
          ["Medications", "Diuretics, Immunosuppressants, Thiazides"]
        ],
        ORANGE
      ),

      spacer(),
      new Paragraph({
        children: [
          new TextRun({ text: "Key Point: ", bold: true, color: RED, font: "Arial", size: 22 }),
          new TextRun({ text: "No matter the cause, HIGH URIC ACID = HIGH RISK of gout.", font: "Arial", size: 22 })
        ],
        shading: { type: ShadingType.CLEAR, fill: LIGHT_RED },
        spacing: { before: 80, after: 80 },
        indent: { left: 240 }
      }),

      spacer(),

      // ============ SECTION 2: PATHOPHYSIOLOGY ============
      sectionBox("2. PATHOPHYSIOLOGY (How Gout Develops)", RED),

      para("The process begins with too much uric acid in the blood and ends with severe joint inflammation. Here is the step-by-step flow:", { spaceBefore: 100 }),

      spacer(),

      flowBox("High Purine Diet / Reduced Kidney Excretion", "1A5276"),
      arrow(),
      flowBox("HYPERURICEMIA β€” Too much uric acid builds up in the blood", "2C3E50"),
      arrow(),
      flowBox("Uric acid exceeds saturation point β†’ MSU CRYSTALS form & deposit in joints", RED),
      arrow(),
      flowBox("Neutrophils & Macrophages rush to the joint (immune response)", "7D3C98"),
      arrow(),
      flowBox("NLRP3 Inflammasome activates β€” the 'alarm system' inside immune cells", "1E8449"),
      arrow(),
      flowBox("Release of IL-1Ξ² and TNF-Ξ± (pro-inflammatory chemicals)", ORANGE),
      arrow(),
      flowBox("πŸ”₯ INFLAMMATION β†’ Severe Pain, Redness, Swelling", "C0392B"),

      spacer(),

      h("Key Molecules in Pathophysiology", HeadingLevel.HEADING_3),
      makeTable(
        ["Molecule", "Role"],
        [
          ["IL-1Ξ² (Interleukin-1 beta)", "The MAIN chemical that causes inflammation"],
          ["TNF-Ξ± (Tumor Necrosis Factor alpha)", "Amplifies the inflammatory response"],
          ["NLRP3 Inflammasome", "Alarm sensor inside immune cells; detects crystals and triggers IL-1Ξ² release"]
        ],
        "7D3C98"
      ),

      spacer(),

      // ============ SECTION 3: CLINICAL FEATURES ============
      sectionBox("3. CLINICAL FEATURES β€” 4 Stages of Gout", "1E8449"),

      spacer(),

      makeTable(
        ["Stage", "Name", "What Happens"],
        [
          ["Stage 1", "Asymptomatic Hyperuricemia", "High uric acid in blood but NO symptoms. Risk of attacks is increased."],
          ["Stage 2", "Acute Gout Attack", "Sudden, severe pain in one joint (usually the big toe). Peaks in 12-24 hrs. Resolves in 3-14 days even without treatment."],
          ["Stage 3", "Intercritical Gout", "Symptom-free period between attacks. Crystals keep depositing silently."],
          ["Stage 4", "Chronic Tophaceous Gout", "Permanent joint damage. Tophi (urate crystal lumps) appear under the skin. Causes chronic arthritis."]
        ],
        "1E8449"
      ),

      spacer(),

      h("Gout Attack Triggers", HeadingLevel.HEADING_3),
      bullet("Alcohol consumption (especially beer)"),
      bullet("Local joint trauma"),
      bullet("Dietary changes (high-purine meals)"),
      bullet("Certain medications"),

      spacer(),

      h("Physical Examination Findings", HeadingLevel.HEADING_3),
      bullet("Red, hot, swollen, tender joint"),
      bullet("Subcutaneous tophi deposits (lumps under skin)"),
      bullet("Most commonly affects the big toe (1st metatarsophalangeal joint)"),

      spacer(),

      new Paragraph({
        children: [
          new TextRun({ text: "Recurrence Statistics: ", bold: true, color: RED, font: "Arial", size: 22 }),
          new TextRun({ text: "60% get a second attack within 1 year | 80% within 3 years", font: "Arial", size: 22 })
        ],
        shading: { type: ShadingType.CLEAR, fill: LIGHT_RED },
        spacing: { before: 80, after: 80 },
        indent: { left: 240 }
      }),

      spacer(),

      // ============ SECTION 4: DIAGNOSIS ============
      sectionBox("4. DIAGNOSIS", "1A5276"),

      para("Diagnosis is based on clinical findings, laboratory tests, and imaging.", { spaceBefore: 100 }),

      h("Clinical Signs", HeadingLevel.HEADING_3),
      bullet("Sudden, severe joint pain and swelling"),
      bullet("Redness and warmth over the joint"),
      bullet("Usually affects the big toe (1st MTP joint)"),

      spacer(),

      h("Laboratory Tests", HeadingLevel.HEADING_3),
      makeTable(
        ["Test", "Purpose"],
        [
          ["Serum Uric Acid", "Elevated in gout"],
          ["Synovial Fluid Analysis", "MSU crystals seen under microscope (Gold Standard)"],
          ["CBC (Complete Blood Count)", "Rules out infection"],
          ["ESR / CRP", "Elevated during acute attack β€” indicates inflammation"]
        ],
        BLUE
      ),

      spacer(),

      h("Imaging Studies", HeadingLevel.HEADING_3),
      makeTable(
        ["Imaging", "Purpose"],
        [
          ["X-ray", "Detects joint damage in chronic gout"],
          ["Ultrasound", "Shows crystal deposits and soft tissue changes"],
          ["DECT (Dual Energy CT)", "Best for detecting urate crystals accurately"],
          ["MRI", "Shows inflammation and soft tissue detail"]
        ],
        "17A589"
      ),

      spacer(),

      // ============ SECTION 5: MANAGEMENT ============
      sectionBox("5. MANAGEMENT", ORANGE),

      para("Gout management has 3 goals:", { spaceBefore: 100 }),
      bullet("Treat the acute attack (stop the pain NOW)"),
      bullet("Prevent future attacks"),
      bullet("Correct underlying high uric acid levels"),

      spacer(),

      h("Treating Acute Attacks", HeadingLevel.HEADING_2),
      makeTable(
        ["Drug", "Notes"],
        [
          ["NSAIDs", "First line treatment. Use cautiously in elderly patients."],
          ["Colchicine", "0.5 mg twice or three times daily. Reduces inflammation effectively."],
          ["Corticosteroids", "Given as local injection or oral. Used when NSAIDs are contraindicated."]
        ],
        RED
      ),

      spacer(),

      h("Long-term / Urate-Lowering Therapy (ULT)", HeadingLevel.HEADING_2),

      para("The goal is to bring uric acid below the crystal-forming threshold:", { spaceBefore: 80 }),

      makeTable(
        ["Guideline", "Target Uric Acid Level"],
        [
          ["BSR (British Society of Rheumatology)", "Below 360 Β΅mol/L (6 mg/dL)"],
          ["EULAR (European League Against Rheumatism)", "Below 300 Β΅mol/L (5 mg/dL)"]
        ],
        BLUE
      ),

      spacer(),

      h("Drug Choice Flowchart", HeadingLevel.HEADING_3),

      flowBox("FIRST LINE: Allopurinol", BLUE),
      new Paragraph({
        children: [new TextRun({ text: "Start: 100 mg/day (lower if elderly or kidney problem) | Max: 900 mg/day\nAdd prophylaxis: Colchicine or NSAID for first few months | Annual uric acid monitoring", font: "Arial", size: 20, color: DARK_GRAY })],
        shading: { type: ShadingType.CLEAR, fill: LIGHT_BLUE },
        spacing: { before: 0, after: 60 },
        indent: { left: 720, right: 720 }
      }),
      arrow(),
      flowBox("If Allopurinol FAILS or is contraindicated β†’ Febuxostat (80 mg/day)", "7D3C98"),
      new Paragraph({
        children: [new TextRun({ text: "More potent than allopurinol | Prophylactic colchicine/NSAID for first 6 months", font: "Arial", size: 20, color: DARK_GRAY })],
        shading: { type: ShadingType.CLEAR, fill: LIGHT_BLUE },
        spacing: { before: 0, after: 60 },
        indent: { left: 720, right: 720 }
      }),
      arrow(),
      flowBox("If patient over-produces uric acid β†’ Uricosurics (Probenecid / Sulfinpyrazone)", "1E8449"),
      new Paragraph({
        children: [new TextRun({ text: "Increases uric acid excretion | Need high urine flow | NOT for kidney disease or kidney stones\nBenzbromarone: For mild-moderate kidney impairment (but has liver toxicity risk)", font: "Arial", size: 20, color: DARK_GRAY })],
        shading: { type: ShadingType.CLEAR, fill: LIGHT_GREEN },
        spacing: { before: 0, after: 60 },
        indent: { left: 720, right: 720 }
      }),
      arrow(),
      flowBox("LAST RESORT (Refractory Tophaceous Gout) β†’ Pegloticase (IV every 2 weeks, up to 6 months)", RED),
      new Paragraph({
        children: [new TextRun({ text: "Reserved for severe cases | Risk: infusion reactions and antibody development", font: "Arial", size: 20, color: DARK_GRAY })],
        shading: { type: ShadingType.CLEAR, fill: LIGHT_RED },
        spacing: { before: 0, after: 80 },
        indent: { left: 720, right: 720 }
      }),

      spacer(),

      h("Lifestyle Changes (Very Important!)", HeadingLevel.HEADING_2),
      makeTable(
        ["What to DO", "What to AVOID"],
        [
          ["Lose weight", "High-purine foods (seafood, offal/organ meats)"],
          ["Drink plenty of water", "Alcohol (especially beer)"],
          ["Switch to ACE inhibitors (if on thiazides)", "Thiazide diuretics (if possible)"],
          ["Follow low-purine diet", "Fructose-rich drinks and processed foods"]
        ],
        "1E8449"
      ),

      spacer(),

      // ============ SECTION 6: QUICK SUMMARY ============
      sectionBox("6. QUICK SUMMARY TABLE", DARK_GRAY),

      spacer(),

      makeTable(
        ["Feature", "Details"],
        [
          ["What is Gout?", "MSU crystal deposition in joints due to high uric acid"],
          ["Main joint affected", "Big toe (1st metatarsophalangeal joint)"],
          ["Best diagnostic test", "Synovial fluid analysis β€” needle-shaped MSU crystals"],
          ["Acute treatment", "NSAIDs, Colchicine, Steroids"],
          ["Long-term treatment", "Allopurinol (first choice)"],
          ["Backup drug", "Febuxostat (if allopurinol fails)"],
          ["Lifestyle changes", "Avoid purines & alcohol, stay hydrated, lose weight"]
        ],
        DARK_GRAY
      ),

      spacer(),

      new Paragraph({
        children: [
          new TextRun({ text: "Simple Memory Hook: ", bold: true, color: RED, font: "Arial", size: 22 }),
          new TextRun({ text: "More uric acid β†’ crystals in joints β†’ immune overreaction β†’ painful swelling. Treat the attack, then lower uric acid long-term.", italics: true, font: "Arial", size: 22 })
        ],
        shading: { type: ShadingType.CLEAR, fill: LIGHT_ORANGE },
        spacing: { before: 120, after: 120 },
        indent: { left: 240 }
      }),

      spacer(),
    ]
  }]
});

Packer.toBuffer(doc).then(buffer => {
  fs.writeFileSync('/home/daytona/workspace/gout-notes/GOUT_Notes.docx', buffer);
  console.log('Done! File saved.');
}).catch(err => {
  console.error('Error:', err);
  process.exit(1);
});
Running Command

cd /home/daytona/workspace/gout-notes && node create_gout_doc.js 2>&1

Running Command

python /home/daytona/skills/docx/scripts/office/validate.py /home/daytona/worksp…

Running Command

ls -lh /home/daytona/workspace/gout-notes/GOUT_Notes.docx && python3 -c "import …

Your document is ready! Here's the download link:

GOUT Notes

Word Document Β· DOCX

The document includes:
  • Title page with a styled header
  • Introduction & Causes table with risk factor categories
  • Pathophysiology flowchart - step-by-step boxes with arrows (High uric acid β†’ Crystals β†’ Immune response β†’ Inflammation)
  • 4 Stages of Gout in a color-coded table
  • Diagnosis section with lab tests and imaging tables
  • Management section with a drug choice flowchart (Allopurinol β†’ Febuxostat β†’ Uricosurics β†’ Pegloticase)
  • Lifestyle changes table
  • Quick summary table at the end with a memory hook
This is a shared conversation. Sign in to Orris to start your own chat.